| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_TTC3_0019900 | Exon-Exon | chr21:38516825-38525577 | chr21:37144525-37153277 | 968 nt | 0.3647 |
| hsa_TTC3_0020000 | Exon-Exon | chr21:38516825-38534365 | chr21:37144525-37162063 | 1398 nt | 0.3720 |
| hsa_TTC3_0020200 | Exon-Exon | chr21:38516825-38536517 | chr21:37144525-37164215 | 57 nt | 0.3333 |
| hsa_TTC3_0020300 | Exon-Exon | chr21:38516861-38520947 | chr21:37144561-37148647 | 310 nt | 0.3677 |
| hsa_chr21_0074000 | Intergenic-Intergenic | chr21:38516864-38520925 | chr21:37144564-37148625 | 285 nt | 0.3789 |
| hsa_chr21_0074100 | Intergenic-Intergenic | chr21:38518212-38519441 | chr21:37145912-37147141 | 1230 nt | 0.4561 |
| hsa_TTC3_0020400 | Intron-Exon-Intron | chr21:38519065-38520947 | chr21:37146765-37148647 | 941 nt | 0.3624 |
| hsa_TTC3_0020700 | Exon-Exon | chr21:38519781-38522470 | chr21:37147481-37150170 | 318 nt | 0.3648 |
| hsa_TTC3_0020900 | Exon-Exon | chr21:38519781-38525577 | chr21:37147481-37153277 | 847 nt | 0.3625 |
| hsa_TTC3_0021000 | Exon-Exon | chr21:38519814-38520947 | chr21:37147514-37148647 | 192 nt | 0.3646 |
A study in humans demonstrated that the circTTC3 shows a significant decrease in the peripheral blood of Alzheimer's disease patients, suggesting its potential to distinguish this condition from other dementias [Misir et al. DOI:10.1038/s41418-022-00948-7]. In mice and rats, circTTC3 was markedly upregulated in ischemic myocardium post-myocardial infarction and counteracted hypoxia-induced ATP depletion and apoptotic death in cardiomyocytes via the miR-15b/Arl2 axis [Tian et al. DOI:10.3390/molecules26041155]. It also alleviated hypoxic injury in HaCaT cells via miR-449a/NF-κB and PI3K/AKT pathways [Huang et al. DOI:10.3390/cells11091381].